Please login to the form below

Not currently logged in
Email:
Password:

Symtuza

This page shows the latest Symtuza news and features for those working in and with pharma, biotech and healthcare.

Janssen’s single tablet Symtuza gains NHS England funding 

Janssen’s single tablet Symtuza gains NHS England funding 

Janssen and Gilead combination first to reach patients. J anssen has gained NHS England funding for its HIV treatment combination Symtuza, which combines a four drug regimen in a single tablet. ... The ruling puts Symtuza ahead of newly EU-approved

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics